author-photo

Miyagi Hbpcog

3

Papers

1

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

A phase II multicenter trial of mFOLFOX6 as adjuvant treatment after resection of liver metastases from colorectal cancer (Miyagi-HBPCOG Trial-001): The final data of progression-free survival.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A phase II study of neoadjuvant chemotherapy with bevacizumab plus mFOLFOX6 for resectable synchronous liver metastasis (SLM) from colorectal cancer: The first report of the Miyagi Hepato-Biliary Pancreatic Clinical Oncology Group.

2012 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
A phase II multicenter trial of neoadjuvant chemotherapy FOLFOX6 in combination with bevacizumab for patients with resectable synchronous liver metastases after R0-resections of primary colorectal cancers: The interim analysis.

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)